Hydrocortison

Overdose

No special precautions or antidotes are likely to be needed.

Shelf life

3 years.

Contraindications

The product should not be used on the eyes or face, the ano-genital area or on broken or infected skin including impetigo, cold sores, acne, athlete's foot, scabies or infected bites or stings.

Incompatibilities

None known.

List of excipients

White soft paraffin

Liquid paraffin

Phenoxyethanol

Purified water

Cetomacrogol emulsifying wax

Hydrocortison price

We have no data on the cost of the drug.
However, we will provide data for each active ingredient

Pharmaceutical form

A smooth, white cream

Undesirable effects

Treatment with hydrocortisone is usually well tolerated but treatment should be stopped if symptoms of hypersensitivity occur.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

Preclinical safety data

There are no preclinical safety data of relevance to the consumer.

Therapeutic indications

Insect bite and sting reactions

Pharmacodynamic properties

Hydrocortisone is a corticosteroid which has anti-inflammatory activity.

Pharmacokinetic properties

Not applicable.

Date of revision of the text

21 November 2014

Name of the medicinal product

Boots Bite and Sting Relief Hydrocortisone Cream

Marketing authorisation holder

The Boots Company PLC

1 Thane Road West

Nottingham

NG2 3AA

Special precautions for storage

Do not store above 25°C.

Nature and contents of container

Internally lacquered collapsible aluminium membrane-sealed tube with a polypropylene cap. Pack size is 10g.

Marketing authorisation number(s)

PL 00014/0658

Qualitative and quantitative composition

Hydrocortisone Acetate BP 1.0% w/w

Special warnings and precautions for use

The product labelling shall include the following statements:

If the condition does not improve consult your doctor. Do not use on the eyes or face, anal or genital areas or on broken skin or infected skin, e.g. impetigo, cold sores, acne, athlete's foot, scabies or infected bites or stings. Do not use for other bites or stings or for other skin conditions.

Effects on ability to drive and use machines

None known.

Dosage (Posology) and method of administration

For topical administration.

Apply sparingly to a small area, once or twice a day, for a maximum of 2-3 days. Do not use in pregnancy without medical advice or in children under 10.

Special precautions for disposal and other handling

None.

Date of first authorisation/renewal of the authorisation

30/01/2008